Frontispiz: A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors
Immunotherapeutic Agents. A NIR-light-activated and lysosomal-targeted PtII metallacycle for evoking of immunogenic cell death that potentiates cancer immunotherapy of deep-seated tumors is reported by Peter J. Stang, Yan Sun, Yao Sun et al. in their Research Article (e202406392).
Authors
- Meiqin Li
- Chonglu Li (ORCID: https://orcid.org/0009-0009-2175-098X)
- Yao Sun (ORCID: https://orcid.org/0000-0002-6519-7436)
- Yuling Xu (ORCID: https://orcid.org/0000-0002-1139-0855)
- Peter J. Stang (ORCID: https://orcid.org/0000-0002-2307-0576)
- Yan Sun (ORCID: https://orcid.org/0000-0001-7001-7834)
- Le Tu (ORCID: https://orcid.org/0000-0001-7564-7595)
- Jiaxing Du
Institutions
- Henan University (CN)
- University of Utah (US)
- Central China Normal University (CN)
Publication Details
- Journal
- Angewandte Chemie
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/ange.202483761
- Citations
- 4
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.74